FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77350
News▲ Bullish
CytoMed Therapeutics (NASDAQ: GDTC) chairman buys shares, reports a 24.92% stake.
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A chairman buying to a 24.92% stake signals insider conviction, though it is a small-cap with limited liquidity.
Chairman accumulates nearly a quarter stake
CATALYST TO WATCH
Further insider purchases or trial news
MAIN RISK
Concentrated ownership, thin liquidity
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
An amendment to EUDA Health (EUDA)'s governing documents was filed on October 5, 2026.2026-10-13 10:30 UTC
An amendment to EUDA Health (EUDA)'s governing documents was filed on October 5, 2026.2026-10-13 10:30 UTC
→CORRELATIONshares Healthcare
Bambusa, Aspen and Tang added to IPO pipeline - pharmaphorum2026-10-13 10:51 UTC
Bambusa, Aspen and Tang added to IPO pipeline - pharmaphorum2026-10-13 10:51 UTC
→CORRELATIONshares Healthcare
AMSURG Partners with Euclid Endoscopy Center to Expand Access to Care in San Diego County2026-10-13 11:00 UTC
AMSURG Partners with Euclid Endoscopy Center to Expand Access to Care in San Diego County2026-10-13 11:00 UTC
→CORRELATIONshares Healthcare
Jocasta Neuroscience and Diamond Therapeutics Announce Research Program to Explore Non-Hallucinogenic Psychedelic-Inspired Compounds for Cognitive Impairment and Neurodegeneration2026-10-13 11:00 UTC
Jocasta Neuroscience and Diamond Therapeutics Announce Research Program to Explore Non-Hallucinogenic Psychedelic-Inspired Compounds for Cognitive Impairment and Neurodegeneration2026-10-13 11:00 UTC
→CORRELATIONshares Healthcare
RED QUEEN BIO APPOINTS IAN WATSON AS CHIEF GOVERNMENT AFFAIRS OFFICER2026-10-13 11:05 UTC
RED QUEEN BIO APPOINTS IAN WATSON AS CHIEF GOVERNMENT AFFAIRS OFFICER2026-10-13 11:05 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.